Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery
Crossref DOI link: https://doi.org/10.1007/s00268-017-3894-x
Published Online: 2017-01-20
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamashita, Kotaro
Makino, Tomoki
Tanaka, Koji
Yamasaki, Makoto
Yamamoto, Masaaki
Miyazaki, Yasuhiro
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Nakajima, Kiyokazu
Takiguchi, Shuji
Mori, Masaki
Doki, Yuichiro
Version of Record valid from 2017-01-20
License valid from 2017-01-20